NTHI vs WST · rev $40.0K vs P/E 35, rev $1.72B
NeOnc Technologies Holdings, Inc. Common Stock (NTHI) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
NeOnc Technologies Holdings, Inc. Common Stock (NTHI) is a biotechnology company listed on NASDAQ.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported NTHI revenue for 2025-12-31 was $40.0K. Net income was -$62.1M. Revenue was down 51.8% from 2024-12-31 to 2025-12-31. NTHI currently screens at market cap $117.3M.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
NTHI currently screens at market cap $117.3M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the NTHI and WST stock pages for the full models.
Not investment advice.